WallStreetZenWallStreetZen

NASDAQ: PDEX
Pro Dex Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PDEX

Based on 1 analyst offering 12 month price targets for Pro Dex Inc

Min Forecast
$56.00+41.56%
Avg Forecast
$56.00+41.56%
Max Forecast
$56.00+41.56%

Should I buy or sell PDEX stock?

Based on 1 analyst offering ratings for Pro Dex Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their PDEX stock forecasts and price targets.

PDEX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-27

1 of 1

Forecast return on equity

Is PDEX forecast to generate an efficient return?

Company
22%
Industry
15.66%
Market
56.76%
PDEX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PDEX forecast to generate an efficient return on assets?

Company
12.08%
Industry
11.22%
PDEX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PDEX earnings per share forecast

What is PDEX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$2.30-19.3%
Avg 2 year Forecast
$2.38-16.49%
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PDEX revenue forecast

What is PDEX's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$67.9M+5.89%
Avg 2 year Forecast
$70.0M+9.16%
PDEX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PDEX earnings growth forecast

How is PDEX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
-19.3%
Industry
30.2%
Market
57.17%
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PDEX revenue growth forecast

How is PDEX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
5.89%
Industry
6.27%
Market
55.62%
PDEX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PDEX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PDEX vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
PDEX$39.56$56.00+41.56%Buy
INFU$6.21N/AN/A
CUPR$5.73N/AN/A
ZTEK$1.43N/AN/A
KRMD$3.23$4.83+49.63%Buy
View Top Medical Stocks

Pro Dex Stock Forecast FAQ

Is Pro Dex Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PDEX) stock is to Buy PDEX stock.

Out of 1 analyst, 0 (0%) are recommending PDEX as a Strong Buy, 1 (100%) are recommending PDEX as a Buy, 0 (0%) are recommending PDEX as a Hold, 0 (0%) are recommending PDEX as a Sell, and 0 (0%) are recommending PDEX as a Strong Sell.

If you're new to stock investing, here's how to buy Pro Dex stock.

What is PDEX's earnings growth forecast for 2025-2026?

(NASDAQ: PDEX) Pro Dex's forecast annual earnings growth rate of -19.3% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 30.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Pro Dex's earnings in 2025 is $9,368,000.On average, 1 Wall Street analyst forecast PDEX's earnings for 2025 to be $7,500,399, with the lowest PDEX earnings forecast at $7,500,399, and the highest PDEX earnings forecast at $7,500,399.

In 2026, PDEX is forecast to generate $7,761,282 in earnings, with the lowest earnings forecast at $7,761,282 and the highest earnings forecast at $7,761,282.

What is PDEX's revenue growth forecast for 2025-2026?

(NASDAQ: PDEX) Pro Dex's forecast annual revenue growth rate of 5.89% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.

Pro Dex's revenue in 2025 is $64,124,000.On average, 1 Wall Street analysts forecast PDEX's revenue for 2025 to be $221,424,820, with the lowest PDEX revenue forecast at $221,424,820, and the highest PDEX revenue forecast at $221,424,820.

In 2026, PDEX is forecast to generate $228,273,010 in revenue, with the lowest revenue forecast at $228,273,010 and the highest revenue forecast at $228,273,010.

What is PDEX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: PDEX) forecast ROA is 12.08%, which is higher than the forecast US Medical Instruments & Supplies industry average of 11.22%.

What is PDEX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PDEX price target, the average PDEX price target is $56.00, with the highest PDEX stock price forecast at $56.00 and the lowest PDEX stock price forecast at $56.00.

The Wall Street analyst predicted that Pro Dex's share price could reach $56.00 by May 27, 2026. The average Pro Dex stock price prediction forecasts a potential upside of 41.56% from the current PDEX share price of $39.56.

What is PDEX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: PDEX) Pro Dex's current Earnings Per Share (EPS) is $2.85. On average, analysts forecast that PDEX's EPS will be $2.30 for 2025, with the lowest EPS forecast at $2.30, and the highest EPS forecast at $2.30. In 2026, PDEX's EPS is forecast to hit $2.38 (min: $2.38, max: $2.38).

What is PDEX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: PDEX) forecast ROE is 22%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.